/Companies

Sorrento Therapeutics

San Diego, US · Founded 2009 · 7 known investors

Find your way into Sorrento Therapeutics

Founders & leadership

Sorrento Therapeutics was founded in 2009 by Henry Ji, Ph.D..

HJ
Henry Ji, Ph.D.Founder
RG
Richard G. VincentExecutive

Board

JH
Jane H. Hsiao, Ph.D., MBABoard director
GL
Glenn L. HalprynBoard director
KJ
Kim Janda, Ph.D.Board director
CL
Curtis Lockshin, Ph.D.Board director

Investors · 7

Also in the syndicate · 4

BNH InvestmentKorea OmegaSorrento TherapeuticsleadThe Foundation for Prader-Willi Research

Funding

SEC filings, press & company announcements

$2M disclosed across 1 of 2 rounds · 2011–2021

▶$2MraisedJan 2012 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard G. VincentExecutive Officer
  • Henry Ji, Ph.D.Executive Officer, Director
  • Jane H. Hsiao, Ph.D., MBADirector
  • Kim Janda, Ph.D.Director
  • Glenn L. HalprynDirector
  • Curtis Lockshin, Ph.D.Director
Offering amount
$2M
Amount sold
$2M
Minimum investment
$1
First sale
Dec 2011
Incorporated
Corporation, Delaware, 2009
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Sorrento Therapeutics?
Sorrento Therapeutics was founded by Henry Ji, Ph.D. in 2009.
Who are Sorrento Therapeutics's investors?
Sorrento Therapeutics's investors include Ally Bridge Group, Premier Partners, Vickers Venture Partners.
How much funding has Sorrento Therapeutics raised?
Sorrento Therapeutics has disclosed $2M raised across 1 of its 2 known rounds.
Where is Sorrento Therapeutics headquartered?
Sorrento Therapeutics is headquartered in San Diego, US.